Journal of the Pancreas holds a reputation of one of the most reliable peer-reviewed journal in pancreatic cancer. The Journal boasts of eminent editorial board and expert reviewers who look after the entire peer-reviewing process through editorial manager.
Pancreatic cancer is a malignant neoplasm originating from transformed cells arising in tissues forming the pancreas. Pancreatic cancer (cancer of the pancreas) mainly occurs in people aged over 60. If it is diagnosed at an early stage, then an operation to remove the cancer gives some chance of a cure. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. Both the exocrine and endocrine cells of the pancreas can form tumors. But tumors formed by the exocrine cells are much more common. When someone says that they have pancreatic cancer, they usually mean an exocrine pancreatic cancer. Not all of the tumors in the pancreas are cancer. A small number are not cancer (they are benign). Pancreatic cancer cells do not experience programmatic death, but instead continue to grow and divide.
Journal of the Pancreas is published by OMICS Group, one of the reputed Open Access publishers. OMICS Group, the leading scientific event organizer involved in systematic maintenance of more than 700+ peer-reviewed journals supported by very efficient editorial board, having more than 3 millionâs reader database is involved in successfully organizing around 3000+ International Scientific Conferences annually through which a strong association is being built up with industry and academia to achieve international standards and authorized criterion
Last date updated on June, 2014